Search Results

You are looking at 21 - 30 of 1,186 items for :

  • "screening" x
  • Refine by Access: All x
Clear All
Full access

Geographic Accessibility and Completion of Initial Low-Dose CT-Based Lung Cancer Screening in an Urban Safety-Net Population

Sofia Yi, Rutu A. Rathod, Vijaya Subbu Natchimuthu, Sheena Bhalla, Jessica L. Lee, Travis Browning, Joyce O. Adesina, Minh Do, David Balis, Juana Gamarra de Wiliams, Ellen Kitchell, Noel O. Santini, David H. Johnson, Heidi A. Hamann, Simon J. Craddock Lee, Amy E. Hughes, and David E. Gerber

Background Despite a clear mortality benefit, 1 US Preventive Services Task Force (USPSTF) endorsement, and Centers for Medicare & Medicaid coverage, uptake of lung cancer screening with annual low-dose CT (LDCT) remains remarkably limited. As

Full access

Cervical Cancer Screening

Edward E. Partridge, Nadeem Abu-Rustum, Anna Giuliano, Stewart Massad, Joan McClure, Mary Dwyer, and Miranda Hughes

recent changes to cervical cancer screening recommendations and management of abnormal screening test results Describe the rationale behind the recent changes in management for cervical cancer screening Overview Cervical cytology screening

Full access

Disparities in Electronic Screening for Cancer-Related Psychosocial Distress May Promote Systemic Barriers to Quality Oncologic Care

Thomas L. Sutton, Marina Affi Koprowski, Jeffrey A. Gold, Benjamin Liu, Alison Grossblatt-Wait, Caroline Macuiba, Andrea Lehman, Susan Hedlund, Flavio G. Rocha, Jonathan R. Brody, and Brett C. Sheppard

Background Screening for psychosocial distress in patients with cancer has become a well-established component of integrative oncologic care, as timely identification of distress and appropriate referrals have been shown to improve well

Full access

NCCN Guidelines as a Model of Extended Criteria for Lung Cancer Screening

Brady J. McKee, Shawn Regis, Andrea K. Borondy-Kitts, Jeffrey A. Hashim, Robert J. French Jr, Christoph Wald, and Andrea B. McKee

Background NCCN, the Centers for Medicare & Medicaid Services (CMS), and the US Preventive Services Task Force (USPSTF) recommend annual CT lung screening (CTLS) for current and former heavy smokers meeting the National Lung Screening Trial

Full access

Factors Associated With False-Positive Recalls in Mammography Screening

Xinhe Mao, Wei He, Keith Humphreys, Mikael Eriksson, Natalie Holowko, Fredrik Strand, Per Hall, and Kamila Czene

Background Mammography screening reduces breast cancer mortality by an estimated 26% to 41%. 1 , 2 However, false-positive recalls—recalling women with abnormal mammograms who, on further testing, are not found to have breast cancer—can cause

Full access

Lung Cancer Screening With Low-Dose Computed Tomography: Costs, National Expenditures, and Cost-Effectiveness

Bernardo H. L. Goulart, Mark E. Bensink, David G. Mummy, and Scott D. Ramsey

disease is rarely curable. Lung cancer screening tests can potentially reduce cancer mortality through detecting tumors at earlier stages, when treatments have higher chances of cure. 2 , 3 The NCI-sponsored National Lung Screening Trial (NLST) is the

Full access

Current Status of Distress Screening in Designated Cancer Hospitals: A Cross-Sectional Nationwide Survey in Japan

Toru Okuyama, Yoshiyuki Kizawa, Tatsuya Morita, Hiroya Kinoshita, Megumi Uchida, Asami Shimada, Akemi Shirado Naito, and Tatsuo Akechi

distress screening, 8 , 11 but recent evidence indicates that patients with cancer may not obtain a substantial benefit from screening itself. 12 – 14 Screening is considered just one step in a comprehensive screening program that consists of detailed

Full access

Colorectal Cancer Screening

Randall W. Burt, James S. Barthel, Kelli Bullard Dunn, Donald S. David, Ernesto Drelichman, James M. Ford, Francis M. Giardiello, Stephen B. Gruber, Amy L. Halverson, Stanley R. Hamilton, Mohammad K. Ismail, Kory Jasperson, Audrey J. Lazenby, Patrick M. Lynch, Edward W. Martin Jr., Robert J. Mayer, Reid M. Ness, Dawn Provenzale, M. Sambasiva Rao, Moshe Shike, Gideon Steinbach, Jonathan P. Terdiman, and David Weinberg

Colorectal Cancer Screening Clinical Practice Guidelines in Oncology NCCN Categories of Evidence and Consensus Category 1: The recommendation is based on high-level evidence (e.g., randomized controlled trials) and there is uniform NCCN

Full access

Lung Cancer Screening, Version 1.2015

Douglas E. Wood, Ella Kazerooni, Scott L. Baum, Mark T. Dransfield, George A. Eapen, David S. Ettinger, Lifang Hou, David M. Jackman, Donald Klippenstein, Rohit Kumar, Rudy P. Lackner, Lorriana E. Leard, Ann N.C. Leung, Samir S. Makani, Pierre P. Massion, Bryan F. Meyers, Gregory A. Otterson, Kimberly Peairs, Sudhakar Pipavath, Christie Pratt-Pozo, Chakravarthy Reddy, Mary E. Reid, Arnold J. Rotter, Peter B. Sachs, Matthew B. Schabath, Lecia V. Sequist, Betty C. Tong, William D. Travis, Stephen C. Yang, Kristina M. Gregory, and Miranda Hughes

, participants will be able to: Integrate into professional practice the updates to NCCN Guidelines for Lung Cancer Screening Describe the rationale behind the decision-making process for developing the NCCN Guidelines for Lung Cancer Screening

Full access

Screening Process Failures for Hepatocellular Carcinoma

Amit G. Singal, Jorge A. Marrero, and Adam Yopp

with cirrhosis. 2 , 6 , 7 The goals of surveillance are to detect HCC at an early stage when it is amenable to curative therapy and to reduce all-cause mortality. 8 Effective implementation of the screening process requires surveillance (obtaining an